Modified natural cycle for embryo transfer using frozen-thawed blastocysts: A satisfactory option

Eur J Obstet Gynecol Reprod Biol. 2017 Jun:213:58-63. doi: 10.1016/j.ejogrb.2017.04.010. Epub 2017 Apr 6.

Abstract

Objective: To describe pregnancy outcomes of frozen-thawed blastocysts cycles using modified natural cycle frozen embryo transfers (NC-FET) and down-regulated hormonally controlled frozen embryo transfers (HC-FET) protocols.

Study design: This retrospective cohort study included all patients undergoing either modified NC-FET or down-regulated HC-FET using frozen-thawed day 5 embryos. Cycles with donor blastocysts were excluded. Four hundred twenty eight patients underwent a total of 493 FET cycles. Patients with regular menses and evidence of ovulation underwent modified NC-FET. These patients were given hCG 10,000 IU IM on the day of LH-surge. Vaginal progesterone (P4) was started two days later and blastocyst transfer was planned seven days after detecting the LH surge. Anovulatory patients and some ovulatory patients underwent down-regulated HC-FET. These patients were placed on medroxy-progesterone acetate (10mg) for 10days to bring on menses and were also given a half-dose of GnRH-agonist (GnRH-a) on the third day of medroxy-progesterone acetate. Exogenous estradiol was initiated on the third day of menses. Once serum E2 levels reached >500pg/mL and endometrial lining reached >8mm, intramuscular (IM) P4 in oil was administered. Blastocyst FET was planned 6days after initiating P4. The primary outcomes included clinical pregnancy and delivery rates.

Results: There were 197 patients in the modified NC-FET protocol and 181 in the down-regulated HC-FET protocol. Mean age (years), day-3 FSH levels (mIU/mL) and percentage of patients with male factor infertility were significantly higher and mean BMI (kg/m2) was significantly lower in modified NC-FET compared to HC-FET, respectively. Analysis of the first cycle pregnancy outcomes revealed no significant differences in clinical pregnancy rate (54.3% vs. 52.5%) and delivery rate (47.2% vs. 43.6%) between modified NC-FET and HC-FET. Logistic regression analysis showed age (OR=0.939, 95% CI 0.894-0.989, p=0.011), number of blastocysts transferred (OR=1.414, 95% CI 1.046-1.909, p=0.024), and the year of FET (OR=1.127, 95% CI 1.029-1.234, p=0.010) were significant factors impacting clinical pregnancy. An age analysis within three age groups (≤35, 36-39, ≥40) was performed, but no significant difference in clinical pregnancy was observed.

Conclusion: Our data suggests that modified NC-FET protocol has comparable pregnancy outcomes to down-regulated HC-FET when utilizing frozen-thawed day 5 embryos.

Keywords: Blastocysts; Frozen-thawed embryo transfer; Hormonally controlled cycles; Natural cycle.

MeSH terms

  • Administration, Intravaginal
  • Adult
  • Blastocyst / physiology*
  • Chorionic Gonadotropin / administration & dosage
  • Cohort Studies
  • Cryopreservation* / methods
  • Embryo Transfer / methods*
  • Estradiol / administration & dosage
  • Estradiol / blood
  • Female
  • Hot Temperature
  • Humans
  • Luteinizing Hormone / blood
  • Ovulation
  • Pregnancy
  • Pregnancy Outcome*
  • Progesterone / administration & dosage
  • Retrospective Studies

Substances

  • Chorionic Gonadotropin
  • Progesterone
  • Estradiol
  • Luteinizing Hormone